| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $5,469,982 ) |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS142598 | Mechanisms of gain-of-repeat-toxicity and loss-of-C9ORF72-function in FTD and ALS | 000 | 1 | NIH | 2/27/2026 | $555,128 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 002 | 6 | NIH | 1/21/2026 | $432,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 001 | 4 | NIH | 3/10/2026 | $62,573 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 000 | 4 | NIH | 1/30/2026 | $563,163 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 5 | NIH | 12/15/2025 | $51,777 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS146544 | Neurodegenerative Mechanisms of ATP13A2-linked Parkinson's Disease and Related Disorders | 000 | 1 | NIH | 3/10/2026 | $582,465 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 004 | 6 | NIH | 3/10/2026 | $48,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01MH139201 | The immunobiological mechanisms of depression in perimenopause | 000 | 2 | NIH | 1/16/2026 | $765,613 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 3 | NIH | 12/16/2025 | $632,177 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 5 | NIH | 2/11/2026 | $666,885 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 000 | 4 | NIH | 12/10/2025 | $434,294 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165580 | Elucidating the Structural Mechanisms of NAIP Receptors in Bacterial Detection and Inflammasome Activation | 000 | 5 | NIH | 12/29/2025 | $480,000 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 001 | 5 | NIH | 12/18/2025 | $315,817 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA268440 | High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader | 000 | 4 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR079174 | 5-methylcytosine oxidation in development and disease | 000 | 5 | NIH | 1/9/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 2 | NIH | 11/24/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31NS139616 | Cortical Neuronal Vulnerability in Parkinson's Disease | 000 | 1 | NIH | 11/17/2025 | -$21,887 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 000 | 2 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 000 | 1 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 000 | 2 | NIH | 1/16/2026 | -$27,061 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30CA268840 | A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer | 000 | 3 | NIH | 1/7/2026 | -$54,537 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R56ES034765 | Molecular mechanisms underlying metabolic reprogramming by paternal benzene exposure | 000 | 1 | NIH | 2/13/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R37CA230748 | High-throughput Epigenomic Mapping of Regulatory Elements in Ovarian Cancer at Basepair Resolution | 000 | 7 | NIH | 11/24/2025 | -$16,425 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS114409 | The contribution of the vermiform appendix to Parkinson's disease | 000 | 5 | NIH | 3/5/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS117137 | Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models | 000 | 5 | NIH | 3/5/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA255506 | Discovery of small molecules targeting the histone acetylation reader ENL | 000 | 4 | NIH | 3/3/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI171984 | The roles of genetics, hormones, and gender in sexually dimorphic immune response | 000 | 3 | NIH | 2/12/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165722 | Ketone Body Metabolism in CD8+ T Cell Responses | 000 | 3 | NIH | 2/5/2026 | $0 |
| | 2026 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA255928 | Understanding the effects of dietary interventions on pancreatic ductal adenocarcinoma therapy cancer | 000 | 4 | NIH | 1/14/2026 | $0 |
| | 2026 | 2023 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA234595 | DNA hypermethylation in lung tumors | 000 | 5 | NIH | 1/14/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $25,339,232 ) (Continued on the next page) |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 001 | 2 | NIH | 8/15/2025 | $51,538 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 001 | 2 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 000 | 2 | NIH | 5/14/2025 | $47,974 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 4 | NIH | 3/4/2025 | $655,853 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35CA209859 | Establishing and Interpreting Abnormal DNA Methylation in Cancer | 001 | 10 | NIH | 6/10/2025 | $1,022,083 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA297713 | Dietary regulation of anti-tumor immunity through caloric restriction | 000 | 1 | NIH | 3/17/2025 | $767,324 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR085095 | Mitochondrial Oxidative Metabolism is a critical determinant of Muscle Satellite Cell fate & function | 000 | 1 | NIH | 8/12/2025 | $1,622,775 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21HD114905 | Fatty acid metabolism in disease models of mitochondrial fatty acid synthesis deficiency. | 001 | 1 | NIH | 8/4/2025 | $0 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21HD114905 | Fatty acid metabolism in disease models of mitochondrial fatty acid synthesis deficiency. | 000 | 1 | NIH | 8/4/2025 | $288,000 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 001 | 1 | NIH | 9/10/2025 | $0 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 000 | 1 | NIH | 7/29/2025 | $50,038 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM160317 | Revealing the Molecular Basis of Microtubule-Intermediate Filament Interactions. | 000 | 1 | NIH | 8/9/2025 | $528,000 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA293261 | Targeting PTGIR-Prostacyclin Signaling to Overcome T Cell Exhaustion and Enhance Anti-Tumor Immunity | 000 | 1 | NIH | 7/30/2025 | $112,234 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI188367 | Metabolic targeting of CD4 T cells in CNS autoimmunity | 000 | 1 | NIH | 7/8/2025 | $790,222 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA269394 | Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death | 003 | 4 | NIH | 5/20/2025 | $496,811 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 3 | NIH | 9/15/2025 | $249,000 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 001 | 3 | NIH | 9/22/2025 | $249,000 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 001 | 3 | NIH | 9/22/2025 | -$249,000 |
|
